Ben Westphalen: Revolutionary way of creating access to molecularly guided treatment options

Ben Westphalen, Chair of Translational Research and Precision Medicine Working Group at ESMO,  shared on X:         ,

“The Dutch Drug Rediscovery Protocol (DRUP) trial is a revolutionary way of creating access to molecularly guided treatment options for patients with cancer.

Updated information out in Acta Oncologica.“

Source: Ben Westphalen/X